Vitrology

Vitrology, now operating as SGS Vitrology, is a leading biopharmaceutical contract testing organization (CRO) based in Glasgow, Scotland. Established in 2007 and acquired by SGS in 2012, the company specializes in biosafety testing services essential for the regulatory approval and release of biologic therapeutics, including vaccines, gene therapies, and recombinant proteins. Its core capabilities encompass virology, cell and molecular biology, microbiology, and electron microscopy, all conducted within GLP and cGMP-compliant facilities. Vitrology gained significant prominence for its role in the global response to the COVID-19 pandemic, supporting the batch release of billions of vaccine doses for partners like AstraZeneca. Today, it serves as the Global Centre of Excellence for Biosafety within the SGS network, providing critical safety assays and regulatory consultancy to the global pharmaceutical industry.